Massive survey aims to uncover Haemophilia's hidden toll in Asia-Pacific

NCT ID NCT07163260

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 33 times

Summary

This study collects information from doctors and patient groups across Asia and the Pacific to learn more about haemophilia—a bleeding disorder. Researchers will estimate how many people have the condition, how many new cases occur, and how often patients develop complications. No treatments are given; the goal is simply to gather knowledge to improve care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HAEMOPHILIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Novo Nordisk Investigational Site

    Bangalore, Karnataka, 560 066, India

  • Novo Nordisk Investigational Site

    Kuala Lumpur, 50470, Malaysia

  • Novo Nordisk Investigational Site

    Seoul, South Korea

  • Novo Nordisk Investigational Site

    Bangkok, 10500, Thailand

Conditions

Explore the condition pages connected to this study.